PTB Domains of IRS-1 and Shc Have Distinct but Overlapping Binding Specificities (*)

PTB domains are non-Src homology 2 (SH2) phosphotyrosine binding domains originally described in the receptor tyrosine kinase substrate, Shc. By serial truncation, we show that a 174-residue region of Shc p52 (33-206) has full PTB activity. We also show that a 173-residue region of insulin receptor substrate-1 (IRS-1; residues 144-316) has related PTB activity. In vitro both domains bind directly to activated insulin receptors. Binding is abrogated by substitution of Tyr-960 and selectively inhibited by phosphopeptides containing NPXY sequences. Phosphopeptide assays developed to compare PTB domain specificities show that the Shc PTB domain binds with highest affinity to XNββpY motifs derived from middle T (mT), TrkA, ErbB4, or epidermal growth factor receptors ( = hydrophobic, β = β-turn forming); the IRS-1 PTB domain does not bind with this motif. In contrast, both the Shc and IRS-1 PTB domains bind XXNββpY sequences derived from insulin and interleukin 4 receptors, although specificities vary in detail. Shc and IRS-1 are phosphorylated by distinct but overlapping sets of receptor-linked tyrosine kinases. These differences may be accounted for by the inherent specificities of their respective PTB domains.

[1]  William Arbuthnot Sir Lane,et al.  Role of IRS-2 in insulin and cytokine signalling , 1995, Nature.

[2]  S. Shoelson,et al.  Specificity of the PTB Domain of Shc for β Turn-forming Pentapeptide Motifs Amino-terminal to Phosphotyrosine (*) , 1995, The Journal of Biological Chemistry.

[3]  A. Ullrich,et al.  Shc Binding to Nerve Growth Factor Receptor Is Mediated by the Phosphotyrosine Interaction Domain (*) , 1995, The Journal of Biological Chemistry.

[4]  L. Cantley,et al.  The Phosphotyrosine Interaction Domain of SHC Recognizes Tyrosine-phosphorylated NPXY Motif (*) , 1995, The Journal of Biological Chemistry.

[5]  C. Turck,et al.  PTB domain binding to signaling proteins through a sequence motif containing phosphotyrosine. , 1995, Science.

[6]  J. Blenis,et al.  The Pleckstrin Homology Domain in Insulin Receptor Substrate-1 Sensitizes Insulin Signaling (*) , 1995, The Journal of Biological Chemistry.

[7]  A. Craparo,et al.  Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain , 1995, Molecular and cellular biology.

[8]  T. Pawson,et al.  A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides , 1995, Current Biology.

[9]  Tony Pawson,et al.  Protein modules and signalling networks , 1995, Nature.

[10]  D. Baltimore,et al.  Modular binding domains in signal transduction proteins , 1995, Cell.

[11]  B. Margolis,et al.  A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors. , 1994, The Journal of biological chemistry.

[12]  L. Williams,et al.  An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. , 1994, Science.

[13]  T. O’Neill,et al.  Characterization of an interaction between insulin receptor substrate 1 and the insulin receptor by using the two-hybrid system , 1994, Molecular and cellular biology.

[14]  T Pawson,et al.  Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. , 1994, Oncogene.

[15]  B. Neel,et al.  SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides. , 1994, The Journal of biological chemistry.

[16]  M. White,et al.  Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1 , 1993, Molecular and cellular biology.

[17]  C. Kahn,et al.  Human Skeletal Muscle Insulin Receptor Substrate-1: Characterization of the cDNA, Gene, and Chromosomal Localization , 1993, Diabetes.

[18]  C. Kahn,et al.  Insulin stimulates serine and tyrosine phosphorylation in the juxtamembrane region of the insulin receptor. , 1993, The Journal of biological chemistry.

[19]  J. Schlessinger,et al.  Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding. , 1993, Biochemistry.

[20]  T. Pawson,et al.  Insulin-induced phosphorylation of the 46- and 52-kDa Shc proteins. , 1993, The Journal of biological chemistry.

[21]  S. Shoelson,et al.  Insulin receptor autophosphorylation occurs asymmetrically. , 1993, The Journal of biological chemistry.

[22]  Sheila M. Thomas,et al.  Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases , 1992, Nature.

[23]  M. White,et al.  The insulin receptor juxtamembrane region contains two independent tyrosine/beta-turn internalization signals , 1992, The Journal of cell biology.

[24]  T. Pawson,et al.  A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction , 1992, Cell.

[25]  C. Kahn,et al.  Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein , 1991, Nature.

[26]  A. Ullrich,et al.  Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity , 1988, Cell.